Clinical Trials
6 trialsNCT05891171 2026-03-31
ARC-25
Arcus Biosciences, Inc.
Phase 1 Active not recruiting
NCT05007106 2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT00627432 2025-02-18
Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Completed
NCT04039867 2023-08-21
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
University of California, Irvine
Phase 2 Terminated
NCT00004203 2013-09-05
Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
University of Chicago
Phase 2 Completed
NCT00186277 2011-03-30
Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
Stanford University
Phase 2 Completed